Human noroviruses cause severe, self-limiting gastroenteritis that typically lasts 24-48 hours. Because of the lack of suitable tissue culture or animal models, the true nature of norovirus pathogenesis remains unknown. We show, for the first time, that noroviruses can infect and replicate in a physiologically relevant 3-dimensional (3-D), organoid model of human small intestinal epithelium. This level of cellular differentiation was achieved by growing the cells on porous collagen-I coated microcarrier beads under conditions of physiological fluid shear in rotating wall vessel bioreactors. Microscopy, PCR, and fluorescent in situ hybridization provided evidence of norovirus infection. Cytopathic effect and norovirus RNA were detected at each of the 5 cell passages for genogroup I and II viruses. Our results demonstrate that the highly differentiated 3-D cell culture model can support the natural growth of human noroviruses, whereas previous attempts that used differentiated monolayer cultures failed.
H uman noroviruses are the leading cause of nonbacterial, self-limiting gastrointestinal illness worldwide (1) (2) (3) (4) . Infected persons may develop symptoms of severe nausea, vomiting, and watery diarrhea within 12-24 hours of exposure and typically remain symptomatic for 1-2 days (5) . Infections may lead to death in immunocompromised persons. The most common routes of norovirus transmission are ingestion of contaminated food and water and person-to-person contact (5) .
Noroviruses are nonenveloped, positive-sense, singlestranded RNA viruses ≈27-35 nm in diameter (6, 7) . They belong to the genus Norovirus in the family Caliciviridae and consist of 3 genogroups (I, II, and IV) that infect humans (8) (9) (10) (11) . On the basis of sequence diversity of the capsid gene, noroviruses can be classified into 8 genetic clusters within GI, 17 in GII, and 1 in GIV (11) .
Understanding of the pathogenesis of human noroviruses has been limited by our inability to propagate these viruses in vitro (12) . Studies of viral attachment to cultured gastrointestinal epithelial cells (Caco-2) using recombinant virus-like particles or infectious noroviruses indicate that specific histo-blood group antigens play a key role in the attachment of the virus to the host cells (13) (14) (15) (16) (17) .
Recently, the first in vitro norovirus cell culture model was reported for a norovirus that infects mice (18, 19) . Asanaka et al. (20) reported production of Norwalk virus particles (norovirus GI.1, the prototype strain) after transfection of cultured kidney cells. However, these models do not answer the fundamental questions of human norovirus attachment to, entry into, and replication within cells of the human gastrointestinal tract, and the resulting symptoms. In vitro differentiation of small intestinal epithelium that approaches physiologic functionality of the in vivo host may allow for the development of a pathogenesis model for norovirus.
Representative models of differentiated human intestinal epithelium can be established by growing cells in 3 dimensions (3-D) on collagen-I-coated porous microcarrier beads in rotating-wall vessel (RWV) bioreactors that model the physiologic fluid-shear environment in their respective organs (21) (22) (23) (24) . The design of the RWV bioreactor is based on the principle that organs and tissues function in a 3-D environment and that this spatial context is necessary for development of cultures that more realisti-cally resemble in vivo tissues and organs (25) . We present the results of our first attempts to infect a physiologically relevant 3-D small intestinal epithelium model (INT-407) with genogroup I and II human noroviruses.
Materials and Methods

Generation of the Small Intestinal Epithelium Model
We summarize results from 4 different infectivity trials that used 3-D small intestinal epithelial cells (Table 1) . The human embryonic intestinal epithelial cell line INT-407 was obtained from the American Type Culture Collection (Manassas, VA, USA) (CCL-6). It was initially grown as standard monolayers in GTSF-2 medium (Hyclone, Logan, UT, USA) containing penicillin/streptomycin and Fungizone (Invitrogen, Carlsbad, CA, USA) in T-75 flasks at 37°C in a 5% CO 2 environment in preparation for seeding into the RWV. GTSF-2 medium is a triplesugar minimal essential medium α-L-15 base supplemented with 10% heat-inactivated fetal bovine serum, 2.2 g/L NaHCO 3 , and 2.5 mg/L insulin-transferrinsodium selenite (26) .
Cells were trypsinized at 70% confluency, and 5 × 10 6 cells were added to the RWV. Cells were assayed for viability by trypan blue dye exclusion. Then they were introduced into the RWV (Synthecon, Inc., Houston, TX, USA) containing 5 mg/mL porous Cytodex-3 microcarrier beads (collagen type-I-coated porous microspheres, average size 175 µ in diameter, Sigma, St. Louis, MO, USA), which produced a final ratio of ≈10 cells/bead (21, 22) . Cells were cultured in the RWV bioreactors, with the rotation speed adjusted to maintain the cell aggregates in suspension during the entire culture duration (≈18-20 rotations/min initial and 24-28 rotations/min final, depending on the size of the aggregates).
Cell growth was monitored daily and fresh medium was replenished by 90% of the total vessel volume each 24-72 hours, depending on the growth and metabolic activity (as monitored by tissue culture media color change) of the cultures. 3-D cells were harvested 35 days after seeding into the RWV except for the fourth infectivity trial, for which aggregates were harvested starting on day 29 and continuing to day 35. Using a 10-mL wide-bore pipette, mature 3-D aggregates were placed into 24-well plates (≈40,000 cells/well) and infected with norovirus on the same day they were harvested.
Before each infectivity assay, immunohistochemical staining was performed on aliquots of the 3-D INT-407 cells to ensure differentiation. Aliquots of the mature tissue aggregates were fixed with paraformaldehyde (4% paraformaldehyde in 1× phosphate-buffered saline [PBS]) for 30 min at room temperature and then stained with antibodies specific for tight junction markers ZO-1, Occludin, Claudin-1, and E-cadherin (Zymed Laboratories [Invitrogen] , South San Francisco, CA, USA). The aliquots were then imaged using confocal laser scanning microscopy (Zeiss Axioplan II microscope, Carl Zeiss, Thornwood, NY, USA). Correct localization of these markers at cell membranes is highly indicative of differentiated cells (22) 407 model also included collagen type-II, fibronectin, sialyl Lewis A antigen, villin, and periodic acid-Schiff staining to show mucin production (22) .
Viruses, diluted 1:5 to 1:1,000 in GTSF-2 media, were applied to the 3-D cell cultures as 0.1-mL aliquots per well across a minimum of 3 wells per time point for each of the infection trials described in Table 1 . Viruses were introduced to the cells by gentle mixing of the aggregates with the viral suspension. The infected aggregates were incubated for 1 h at 37 o C in a 5% CO 2 incubator before being overlaid with 1 mL of fresh GTSF-2 media.
Preparation and Characterization of Virus Stocks
Stool samples were obtained from persons who became ill during acute gastroenteritis outbreaks on cruise ships (identified as samples 149 [GII] and 155 [GI] ) and in a nursing home (identified as flag2 [GII] ). Approximately 1 g of stool was suspended in 0.01 M PBS to obtain a 10%-20% stool suspension (≈5-10 mL). The suspension was vortexed for 60 s, centrifuged at 1,000× g, and processed through a 0.22-µ filter to remove bacterial contamination. Virus samples were stored at -80°C for future assays.
The presence of norovirus in the purified samples was confirmed by reverse transcription-PCR (RT-PCR) and sequencing (10) . BLAST (www.ncbi.nlm.nih.gov/ BLAST) was performed on these sequences to determine genogroup (Table 2) . Stool extracts were screened for other enteric viruses by 3 passages on Buffalo Green Monkey cells and Caco-2 cells grown as conventional monolayers. Stool extracts were also tested for enterovirus by RT-PCR (27) .
Microscopic Analysis
Cellular pathology of 3-D tissue aggregates for the second and third infection trials was documented by using an Olympus DP70 CCD camera and inverted microscope system (Nikon Eclipse TE300, Kanagawa, Japan) at each time point assayed. Subcellular pathology was assessed by using light and transmission electron microscopy (TEM). These samples (≈40,000 cells per well) were fixed in 3.5% glutaraldehyde/0.5% paraformaldehyde in PBS and processed by washing cells 3× with 0.1 M sodium cacodylate buffer (Electron Microscopy Sciences, Hatfield, PA, USA) before incubation in 1% osmium tetroxide diluted in 0.1 M sodium cacodylate buffer for 1 h at room temperature. Cells were washed with buffer and dehydrated by using a graded series of ethanol rinses (33, 50, 75, 90 , and 3× 100% ethanol). Samples were then embedded in hard-grade LR WhiteTM Resin (London Resin Co., Berkshire, England) at 60 o C for 24 h. Block faces were cut into the samples by using a Leica EM Trim (Wetzlar, Germany). Thin (60 nm) and ultrathin (30 nm) sections were cut by using a Diatome Ultra 45º (Biel, Switzerland) diamond knife on a Leica Ultracut UCT ultramicrotome. Thin sections were affixed to microscope slides and stained with toludine blue, then viewed on a Nikon Optiphot-2 light microscope. Ultrathin sections were affixed to copper mesh grids, stained and contrasted with uranyl acetate and lead citrate for 7 min each, and then viewed on a JEOL-2010 (Tokyo, Japan) transmission electron microscope at 106 kV.
Viral RNA Extraction and RT-PCR
RNA from tissue samples was extracted by using either an RNEasy or a ViralAmp RNA extraction kit (Qiagen, Valencia, CA, USA). RT-PCR was performed by using the OneStep RT-PCR kit (Qiagen) according to manufacturers' instructions. Primer sequences for RT-PCR and seminested PCR to amplify the RNA-dependent RNA polymerase gene are listed in Vinje et al. (10) , with the exception of the MP290 primer for seminested PCR, which is 5′-GAYTACTCYCSITGGGAYTC-3′. Viral RNA was subjected to RT-PCR for 60 min at 42º C and 15 min at 95º C to inactivate the RT enzyme and activate Taq. A 3-step PCR was then conducted for 40 cycles (30 s at 94ºC, 30 s at 50ºC, and 30 s at 72º C).
Sequencing
PCR products amplified from cell cultures (P3 passage) of the fourth infection trial were sequenced after cloning into the PGEM-T Easy Vector System (Promega, Madison, WI, USA). Sequences have been deposited in GenBank under accession nos. DQ531707 (for outbreak sample 155) and DQ531708 (for outbreak sample flag2).
Fluorescence in Situ Hybridization
The molecular beacon fluorescence in situ hybridization (FISH) assay performed during the fourth infection trial used modified reverse PCR primer sequences for genogroup I and II viruses (28) . For genogroup 1, the modified probe sequence was 5′-TAMRA-CAGGCCCTTA-GACGCCATCATCATTGCCTG-DABCYL-3′, and for genogroup 2, the modified probe sequence was 5′-TAMRA-CTCGGTCGACGCCATCTTCATTCACACC-GAG-DABCYL-3′. (Underlined sequences for each probe indicate the self-complementary regions.) Cells in the tissue aggregate were fixed in 4% paraformaldehyde for 30 min and then washed 3 times in 1× Dulbecco's PBS (DPBS, Sigma). The weight of the aggregates allowed these to settle by normal gravity to the bottom of the microfuge tube. Tissues were permeabilized with 0.1% Triton X-100 in 1× DPBS for 15 min at room temperature and then washed 3× with 1× DPBS. Molecular beacon (either genogroup 1 or genogroup 2) was suspended to a final concentration of 1 µM in 1× DPBS. The molecular beacon was incubated with the tissues in a water bath for 1 h at 37ºC. The aggregates were then washed 3× with 1× DPBS and transferred to 12-well tissue culture plates. Cell aggregates were imaged by using a Leica confocal laser scanning microscope with a 63× water immersion objective. Captured images were digitally stacked to create 3-D images (VOLOCITY, Improvision Inc., Lexington, MA, USA). In trial 4, we used strain 155 (genogroup I) and flag2 (genogroup II) and infected 3-D INT-407 cells. We followed viral infection for both of these strains through 5 passages in cell culture. With each viral passage, cell cultures showed CPE after 24-48 h, and norovirus RNA for both strains was detected by FISH with genogroup specific molecular beacons ( Figure 5 ). We further sequenced RT-PCR products from the original stool sample that contained strains 155 and flag2 and both strains from passage 3 in cell culture. Only 1 nucleotide substitution for passage 3 flag2 was observed in a 261 bp product, and no nucleotide change was shown for strain 155.
Results
First
Discussion
Our primary goal was to develop an in vitro cell culture assay for human noroviruses. This assay is necessary before we can even begin to understand the mechanisms of pathogenesis for this virus. Our starting point for developing an infectivity assay for human noroviruses was to use the 3-D INT-407 small intestinal epithelium model previously developed for the study of Salmonella pathogenesis (22) . Multiple factors were considered for choosing this model. First, early biopsy studies that used human volunteers indicated that norovirus infection targets the human small intestine (29, 30) . Second, reports showing differentiation of INT-407 cells in 3-D in the RWV essentially produces a "co-culture" model of multiple intestinal cell types (enterocytes, goblet cells, and M cell-like markers) (22) . This phenomenon of multicellularity has been hypothesized as a factor likely needed for norovirus infectivity (12) . Finally, extensive characterization of this model 3-D system (22, 23) showed apical expression of certain cellsurface antigens (e.g., Lewis antigen A), which are thought to be important in the attachment of noroviruses to cells (4, (13) (14) (15) (16) (17) 31) .
However, expression of these antigens alone is not sufficient for a successful cell culture of human norovirus, because our attempts to infect 3-D aggregates established from the large intestinal (colon) cell lines Caco-2 and HT-29 cells were unsuccessful (data not shown). We are not sure whether this phenomenon is due solely or in part to 1) correct presentation of the cell surface receptors that would be necessary for viral attachment and efficient entry into cells or 2) physiologic relevance of the 3-D small intestinal model that confirms previous human biopsy studies that show human noroviruses have an affinity for cells of the small intestine (29, 30) .
We have developed the first successful in vitro cell culture assay for norovirus based on multiple lines of orthogonal evidence. CPE has been a measure of viral infectivity, but this measure alone can be deceiving. Duizer et al. (12) noted CPE in several samples but on further investigation found that it was caused by contaminating Thus, cellular pathology was due to norovirus infection and not caused by other enteric viruses or sample toxicity.
In vitro cell culture models used to study the hostpathogen interaction have benefited from the recognition that organs and tissues function in a 3-D environment and that this spatial context is necessary for development of cultures that more realistically resemble the in vivo tissues and organs from which they were derived (21-23). We used RWV bioreactor technology to engineer 3-D models of human small intestinal epithelium to investigate susceptibility for norovirus infection. This method to generate 3-D organoid models has been used to study Salmonella typhimurium and Escherichia coli infection by using small and large intestinal models (21) (22) (23) 32) , Pseudomonas infection by using lung epithelial models (33) , cytomegalovirus infection by using placental tissue models (34) , and Epstein-Barr virus by using lymphoblastoid cell models (35) .
Our study shows that selecting the appropriate cell line, growing the cells as 3-D aggregates, and infecting them when they are fully differentiated is key for successful in vitro cell culture of human noroviruses. Future research with this model will include further testing of a broader panel of genetically diverse human noroviruses, determining the sensitivity, identifying neutralizing epitopes and protective immune responses, and obtaining a better understanding of the molecular biology of norovirus replication and transcription to develop improved prevention protocols.
